Fierce Pharma亚洲版——艾伯维的双特异性抗体布局、Illumina的中国进口策略及药企高管JPM评论
Fierce Pharma Asia—AbbVie’s bispecific play, Illumina’s China import efforts and pharma execs’ JPM comments - Fierce Pharma
生物技术与制药领域的最新动态
Fierce Pharma Asia—AbbVie’s bispecific play, Illumina’s China import efforts and pharma execs’ JPM comments - Fierce Pharma
Genetic Disease Research Solutions - Illumina
2026: A turning point for precision health - Illumina
JPM26: Illumina working with China on 'a path through' its export troubles, sees academic research environment 'muted' for '26
JPM: Illumina working with China on export troubles, CEO says - Fierce Biotech
Illumina unveils massive cell atlas to speed up drug discovery - San Diego Union-Tribune
Illumina CEO Sees Big Growth Opportunity in China - Bloomberg.com
JPM26: Illumina debuts Billion Cell Atlas to drive AI-driven drug discovery - Pharmaceutical Technology
Illumina Produces Midteens Earnings Growth in 2025, Distancing Itself From the Grail Debacle - Morningstar
Illumina Introduces Illumina Billion Cell Atlas To Accelerate AI Drug Discovery - Nasdaq
Illumina unveils dataset to speed up AI-powered drug discovery - Reuters
Illumina introduces Billion Cell Atlas - TipRanks
Illumina unveils dataset to speed up AI-powered drug discovery - Yahoo Finance
Illumina office building in San Diego - Arizona Daily Sun
Illumina introduces Billion Cell Atlas to accelerate AI and drug discovery - PR Newswire
Illumina launches massive cell atlas to fast-track drug discovery - statnews.com
Assessing Illumina (ILMN) Valuation After New Multiomics Platform And Chief Medical Officer Appointment - Yahoo Finance
Is Illumina’s New CMO Hire and Connected Multiomics Cloud Altering The Investment Case For Illumina (ILMN)? - simplywall.st
Illumina to Announce Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 5, 2026 - Yahoo Finance Singapore
My latest favorite anti-aging device is 20% off on Amazon - New York Post